Physician profile
Eric Ross
NPI 1881033751
$2,475.16
in general payments reported to CMS, 2019-2025
12 companies · $671 in 2025
The $671 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2021: $177 · 2022: $594 · 2023: $400 · 2024: $298 · 2025: $671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,321 · Entertainment: $48.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,320.67 |
| Entertainment | $48.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $518.53 | 2023-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Glaukos Corporation | $485.69 | 2022-2024 | |
| Alcon Vision LLC | $309.80 | 2021-2022 | |
| Nova Eye, INC. | $204.65 | 2025 | |
| Sight Sciences, INC. | $204.35 | 2019-2022 | |
| Maculogix, INC. | $158.37 | 2021 | |
| Ocular Therapeutix, INC. | $149.95 | 2025 | |
| Bausch & Lomb Americas INC. | $147.44 | 2023-2025 | Miebo, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $121.11 | 2019 | |
| Biotissue Holdings INC. | $76.58 | 2019 | |
| Aerie Pharmaceuticals, INC. | $50.58 | 2019 | |
| Optos, INC. | $48.11 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.